新华保险已启动分红重疾险研发工作

Core Viewpoint - The recent guidelines issued by the Financial Regulatory Administration aim to promote the high-quality development of health insurance, particularly supporting well-rated insurance companies in launching dividend-based long-term health insurance products [1] Group 1: Industry Impact - The new policy presents a significant development opportunity for the relatively sluggish critical illness insurance sector, marking an important step in the supply-side reform of the health insurance industry [1] - The implementation of these guidelines is expected to stimulate innovation and product development within the health insurance market [1] Group 2: Company Response - The company, Xinhua Insurance, has acknowledged the importance of the new policy and is actively researching various implementation measures [1] - Xinhua Insurance has initiated the development of dividend-based critical illness insurance products in response to the new regulatory environment [1]